Form 4: Walgreens Boots Alliance Sells 1.86 Million Cencora Shares in Private Transaction

Walgreens Boots Alliance sold 1,859,390 shares of Cencora in a private transaction on May 22, 2024, reducing its beneficial ownership.

Summary

• Walgreens Boots Alliance, Inc. (WBA) reported a change in beneficial ownership of Cencora, Inc. shares on May 22, 2024.
• WBA Holdings, an indirect wholly-owned subsidiary of WBA, sold 1,859,390 shares of Cencora common stock in a private transaction to the Issuer at a price of $215.1244 per share.
• Following the transaction, WBA's beneficial ownership of Cencora shares stands at 24,418,171.
• The shares were acquired in accordance with the Framework Agreement dated March 18, 2013.
• WBA Investments, Inc., a direct wholly-owned subsidiary of WBA and the sole member of WBA Holdings, may also be deemed to beneficially own the securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The document simply reports a transaction. While a large sale could be perceived negatively, it's part of a previously announced plan.

Risks

• Continued sales of Cencora shares by Walgreens Boots Alliance could exert downward pressure on Cencora's stock price.

Future Outlook

The document does not provide specific forward-looking statements regarding Cencora's future performance or Walgreens Boots Alliance's future transactions.

Industry Context

Walgreens Boots Alliance's sale of Cencora shares is part of a previously disclosed plan to divest its stake in the company. This move could be driven by Walgreens' strategic priorities, such as focusing on its core retail pharmacy business or deleveraging its balance sheet. The pharmaceutical distribution industry is competitive, and Cencora's performance is influenced by factors such as drug pricing, regulatory changes, and competition from other distributors.

Comparison to Industry Standards

• Cencora is a major player in the pharmaceutical distribution industry, competing with companies like McKesson and Cardinal Health.
• These companies operate on relatively thin margins and rely on scale and efficiency to generate profits.
• Divestitures and strategic realignments are not uncommon in this industry as companies seek to optimize their portfolios and focus on core competencies.
• Walgreens Boots Alliance's decision to sell part of its stake in Cencora is similar to other companies streamlining their operations to improve financial performance.

Related Party Transactions

• The sale of Cencora shares by Walgreens Boots Alliance Holdings LLC to Cencora is a related party transaction.

Stakeholder Impact

• The sale of shares could have a minor impact on Cencora's stock price in the short term.
• The transaction allows Walgreens Boots Alliance to further streamline its business and focus on its core operations, which could benefit its shareholders.

Key Dates